Starpharma Holdings Limited (SPL.AX)
AUD 0.1
(3.19%)
AUD 0.1
(3.19%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 3.52 Million AUD | -57.35% |
| 2023 | 8.27 Million AUD | 1.01% |
| 2022 | 8.18 Million AUD | 601.71% |
| 2021 | 1.16 Million AUD | -25.86% |
| 2020 | 1.57 Million AUD | 5953.85% |
| 2019 | 26 Thousand AUD | -46.94% |
| 2018 | 49 Thousand AUD | -30.0% |
| 2017 | 70 Thousand AUD | 288.89% |
| 2016 | 18 Thousand AUD | -62.5% |
| 2015 | 48 Thousand AUD | -36.0% |
| 2014 | 75 Thousand AUD | -25.0% |
| 2013 | 100 Thousand AUD | -28.57% |
| 2012 | 140 Thousand AUD | 112.12% |
| 2011 | 66 Thousand AUD | -58.75% |
| 2010 | 160 Thousand AUD | -45.39% |
| 2009 | 293 Thousand AUD | -29.74% |
| 2008 | 417 Thousand AUD | 26.85% |
| 2007 | 328.73 Thousand AUD | -28.15% |
| 2006 | 457.5 Thousand AUD | 227.36% |
| 2005 | 139.75 Thousand AUD | -31.33% |
| 2004 | 203.52 Thousand AUD | -22.77% |
| 2003 | 263.52 Thousand AUD | 0.0% |
| 2002 | - AUD | 0.0% |
| 2001 | - AUD | 0.0% |
| 2000 | - AUD | 0.0% |
| 1999 | - AUD | 0.0% |
| 1998 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q4 | 3.52 Million AUD | 0.0% |
| 2024 Q2 | 3.12 Million AUD | 0.0% |
| 2024 FY | 3.52 Million AUD | -57.35% |
| 2023 Q4 | 8.27 Million AUD | 0.0% |
| 2023 Q2 | 7.84 Million AUD | 0.0% |
| 2023 FY | 8.27 Million AUD | 1.01% |
| 2022 Q4 | 8.18 Million AUD | 0.0% |
| 2022 Q2 | 3.7 Million AUD | 0.0% |
| 2022 FY | 8.18 Million AUD | 601.71% |
| 2021 Q4 | 1.16 Million AUD | 0.0% |
| 2021 FY | 1.16 Million AUD | -25.86% |
| 2021 Q2 | 1.49 Million AUD | 0.0% |
| 2020 FY | 1.57 Million AUD | 5953.85% |
| 2020 Q2 | 1.87 Million AUD | 0.0% |
| 2020 Q4 | 1.57 Million AUD | 0.0% |
| 2019 Q2 | 11 Thousand AUD | 0.0% |
| 2019 Q4 | 26 Thousand AUD | 0.0% |
| 2019 FY | 26 Thousand AUD | -46.94% |
| 2018 Q2 | 36 Thousand AUD | 0.0% |
| 2018 Q4 | 49 Thousand AUD | 0.0% |
| 2018 FY | 49 Thousand AUD | -30.0% |
| 2017 FY | 70 Thousand AUD | 288.89% |
| 2017 Q4 | 70 Thousand AUD | 0.0% |
| 2017 Q2 | - AUD | 0.0% |
| 2016 Q4 | 18 Thousand AUD | 0.0% |
| 2016 Q2 | 3000.00 AUD | 0.0% |
| 2016 FY | 18 Thousand AUD | -62.5% |
| 2015 FY | 48 Thousand AUD | -36.0% |
| 2015 Q4 | 48 Thousand AUD | 0.0% |
| 2015 Q2 | 33 Thousand AUD | 0.0% |
| 2014 FY | 75 Thousand AUD | -25.0% |
| 2014 Q2 | 62 Thousand AUD | 0.0% |
| 2014 Q4 | 75 Thousand AUD | 0.0% |
| 2013 Q2 | - AUD | 0.0% |
| 2013 Q4 | 100 Thousand AUD | 0.0% |
| 2013 FY | 100 Thousand AUD | -28.57% |
| 2013 Q1 | - AUD | -100.0% |
| 2013 Q3 | - AUD | 0.0% |
| 2012 FY | 140 Thousand AUD | 112.12% |
| 2012 Q4 | 140 Thousand AUD | 0.0% |
| 2011 Q4 | 66 Thousand AUD | 0.0% |
| 2011 FY | 66 Thousand AUD | -58.75% |
| 2010 FY | 160 Thousand AUD | -45.39% |
| 2010 Q4 | 160 Thousand AUD | 0.0% |
| 2009 FY | 293 Thousand AUD | -29.74% |
| 2009 Q4 | 293 Thousand AUD | 0.0% |
| 2008 FY | 417 Thousand AUD | 26.85% |
| 2008 Q4 | 417 Thousand AUD | 0.0% |
| 2007 Q4 | 328.73 Thousand AUD | 0.0% |
| 2007 FY | 328.73 Thousand AUD | -28.15% |
| 2006 FY | 457.5 Thousand AUD | 227.36% |
| 2006 Q4 | 457.5 Thousand AUD | 0.0% |
| 2005 FY | 139.75 Thousand AUD | -31.33% |
| 2005 Q4 | 139.75 Thousand AUD | 0.0% |
| 2004 Q4 | 203.52 Thousand AUD | 0.0% |
| 2004 FY | 203.52 Thousand AUD | -22.77% |
| 2003 Q4 | 263.52 Thousand AUD | 0.0% |
| 2003 FY | 263.52 Thousand AUD | 0.0% |
| 2002 FY | - AUD | 0.0% |
| 2002 Q4 | - AUD | 0.0% |
| 2001 Q4 | - AUD | 0.0% |
| 2001 FY | - AUD | 0.0% |
| 2000 FY | - AUD | 0.0% |
| 1999 FY | - AUD | 0.0% |
| 1998 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AdAlta Limited | 2.49 Million AUD | -41.428% |
| Acrux Limited | 1.48 Million AUD | -137.256% |
| Actinogen Medical Limited | 319.06 Thousand AUD | -1005.717% |
| AnteoTech Limited | 23.59 Thousand AUD | -14854.222% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -2118.24% |
| Amplia Therapeutics Limited | 1.56 Million AUD | -125.905% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -1914.262% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Biome Australia Limited | 1.3 Million AUD | -170.196% |
| Biotron Limited | 7130.00 AUD | -49381.066% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| BTC Health Limited | - AUD | -Infinity% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.981% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | -301.008% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| Dimerix Limited | 149.68 Thousand AUD | -2256.981% |
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -2748.469% |
| Hexima Limited | - AUD | -Infinity% |
| Island Pharmaceuticals Limited | 421.96 Thousand AUD | -736.082% |
| Immuron Limited | 173.49 Thousand AUD | -1933.465% |
| Immutep Limited | 1.22 Million AUD | -187.234% |
| Imugene Limited | 1.54 Million AUD | -128.065% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| Memphasys Limited | 4.41 Million AUD | 20.058% |
| Nanollose Limited | 42.53 Thousand AUD | -8195.321% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Noxopharm Limited | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | -411.532% |
| PharmAust Limited | - AUD | -Infinity% |
| Patrys Limited | - AUD | -Infinity% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -1374.115% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | -1015.062% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | -967.519% |
| PYC Therapeutics Limited | 1.11 Million AUD | -217.04% |
| Race Oncology Limited | - AUD | -Infinity% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | -334.917% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 79.776% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 37.596% |